| MODEL IDENTIFIER | CANCER TYPE | CANCER SUBTYPE | DESCRIPTION | DETAILS |
| XL1001 | Acute Lymphoblastic Leukemia | B | NA | VIEW DETAILS |
| XL1002 | Acute Lymphoblastic Leukemia | T | NA | VIEW DETAILS |
| XL1003 | Acute Lymphoblastic Leukemia | B | NA | VIEW DETAILS |
| XL1004 | Acute Lymphoblastic Leukemia | B | XL1004 is a versatile preclinical model suitable for evaluating novel agents targeting Acute Lymphoblastic Leukemia (ALL), enabling robust assessment of antitumor activity and pharmacodynamic response in vivo. | VIEW DETAILS |
| XL1005 | Acute Lymphoblastic Leukemia | B | NA | VIEW DETAILS |
| XL1006 | Acute Lymphoblastic Leukemia | B | NA | VIEW DETAILS |
| XL1007 | Acute Lymphoblastic Leukemia | B | NA | VIEW DETAILS |
| XL1008 | Acute Lymphoblastic Leukemia | T | NA | VIEW DETAILS |
| XL1009 | Acute Lymphoblastic Leukemia | B | NA | VIEW DETAILS |
| XL1010 | Acute Lymphoblastic Leukemia | T | NA | VIEW DETAILS |
| XL1011 | Acute Lymphoblastic Leukemia | B | NA | VIEW DETAILS |
| XL1012 | Acute Lymphoblastic Leukemia | T | NA | VIEW DETAILS |
| XL1013 | Acute Lymphoblastic Leukemia | B | NA | VIEW DETAILS |
| XL1014 | Acute Lymphoblastic Leukemia | B | NA | VIEW DETAILS |
| XL1015 | Acute Lymphoblastic Leukemia | T | NA | VIEW DETAILS |
| XL1016 | Acute Lymphoblastic Leukemia | T | NA | VIEW DETAILS |
| XL1017 | Acute Lymphoblastic Leukemia | B | NA | VIEW DETAILS |
| XL1018 | Acute Lymphoblastic Leukemia | B | NA | VIEW DETAILS |